文献速递乳腺US乳腺X线

乳腺X线摄影联合自动乳腺超声在非致密型乳腺女性中的筛查结局

Screening Outcomes of Supplemental Automated Breast Ultrasound in Women With Nondense Breasts Undergoing Mammography.
PubMed 文献 · Korean J Radiol · 2026-01-01

回顾性分析两所三级机构1683名非致密型乳腺女性2904对筛查检查,检出26例癌症。与单独数字乳腺X线摄影相比,联合自动乳腺超声提高癌症检出率(9.0 vs 7.9/1000次检查,P<0.001)和敏感度(100% vs 88.5%,P<0.001),但降低特异度(95.0% vs 97.9%,P<0.001)。获益主要体现在散在纤维腺体密度女性。

要点

  • 非致密型乳腺女性中,数字乳腺X线摄影联合自动乳腺超声较单用数字乳腺X线摄影提高癌症检出率和敏感度。
  • 联合自动乳腺超声降低特异度,假阳性增加需关注。
  • 仅自动乳腺超声检出的3例癌症均为T1N0期(占11.5%)。

核心结论

  • 在非致密型乳腺女性中,补充自动乳腺超声可提高癌症检出率和敏感度,获益主要见于散在纤维腺体密度女性;几乎完全脂肪型乳腺中联合与单用数字乳腺X线摄影的癌症检出率和敏感度相同。

研究设计与样本

  • 回顾性研究,检索两所三级机构放射学数据库,纳入2020年1月至2023年12月期间同时接受数字乳腺X线摄影和补充自动乳腺超声筛查的无症状非致密型乳腺女性,排除随访数据不足或缺乏最终诊断(包括组织病理学结果)者;共1683名女性(59±10岁)的2904对筛查检查,检出26例癌症;比较单独数字乳腺X线摄影与自动乳腺超声联合数字乳腺X线摄影的性能指标;主要结局为癌症检出率,次要结局为敏感度和特异度;对散在纤维腺体密度和几乎完全脂肪型乳腺女性进行亚组分析。

诊断标准与关键数值

  • 自动乳腺超声联合数字乳腺X线摄影 vs 单独数字乳腺X线摄影:癌症检出率9.0 vs 7.9/1000次检查(P<0.001),敏感度100%(26/26)vs 88.5%(23/26)(P<0.001),特异度95.0%(2735/2878)vs 97.9%(2817/2878)(P<0.001);散在纤维腺体密度女性中,癌症检出率从7.4升至8.5/1000次检查,敏感度从87.0%(20/23)升至100%(23/23)(P<0.001);几乎完全脂肪型乳腺女性中,联合与单用数字乳腺X线摄影的癌症检出率均为16.4/1000次检查,敏感度均为100%(3/3);仅自动乳腺超声检出的癌症3例(11.5% [3/26]),均为T1N0期。

临床应用与阅片要点

  • 在非致密型乳腺女性筛查中,补充自动乳腺超声可提高癌症检出率和敏感度,但特异度降低;获益主要在散在纤维腺体密度女性,几乎完全脂肪型乳腺女性中联合与单用数字乳腺X线摄影的癌症检出率和敏感度相同。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the performance of supplemental automated breast ultrasound (ABUS) added to mammography-based breast cancer screening for women with nondense breasts.

MATERIALS AND METHODS: A retrospective search of radiology databases at two tertiary institutions identified asymptomatic women with nondense breasts who underwent breast cancer screening using both digital mammography (DM) and supplemental ABUS between January 2020 and December 2023. We excluded women without sufficient follow-up data or those without an established final diagnosis, including histopathologic results. The performance measures of DM alone and ABUS combined with DM (ABUS plus DM) were compared. The primary outcome was the cancer detection rate (CDR), and the secondary outcomes were sensitivity and specificity. Subgroup analyses were performed for women with scattered fibroglandular density and almost entirely fatty breasts.

RESULTS: A total of 2,904 pairs of screening examinations were performed in 1,683 women (59 ± 10 years), detecting 26 cancers. In comparison with DM alone, ABUS plus DM showed higher CDR (9.0 vs. 7.9 per 1,000 examinations, P < 0.001), higher sensitivity (100% [26/26] vs. 88.5% [23/26], P < 0.001), and lower specificity (95.0% [2,735/2,878] vs. 97.9% [2,817/2,878], P < 0.001). In women with scattered fibroglandular density, ABUS increased the CDR from 7.4 to 8.5 per 1,000 examinations and improved the sensitivity from 87.0% [20/23] to 100% [23/23] (P < 0.001). In women with almost entirely fatty breasts, ABUS plus DM showed the same CDR (16.4 per 1,000 examinations) and sensitivity (100% [3/3]) as DM alone. Three cancers (11.5% [3/26]), all of which were stage T1N0, were detected only by supplemental ABUS.

CONCLUSION: Supplemental ABUS improved cancer detection and sensitivity in women with nondense breasts, with the benefits primarily observed in those with scattered fibroglandular density.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kwon MR, Lee MY, Moon S, et al. Screening Outcomes of Supplemental Automated Breast Ultrasound in Women With Nondense Breasts Undergoing Mammography. Korean J Radiol. 2026. PMID: 41494673. doi:10.3348/kjr.2025.1114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。